Andere talen Recursion Pharmaceuticals, Inc.

Aandelen

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 22-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
7,6 ^USD	+3,40%		-2,44%	-22,92%

18/04	Recursion Pharmaceuticals Insider verkocht aandelen ter waarde van $367.007, volgens een recent SEC-filing	MT
16/04	Recursion benoemt Najat Khan tot Chief R&D Officer en Chief Commercial Officer	CI

Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing	18/04
Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer	16/04
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer	16/04
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer	16/04
Recursion Appoints Najat Khan as Chief R&D Officer and Chief Commercial Officer	16/04
Recursion to Participate in Upcoming Investor Conference	02/04
Recursion to Participate in Upcoming Investor Conference	02/04
Recursion Publishes Annual Environmental, Social and Governance Report	26/03
50 valores para invertir en IA, salud, movilidad y energía	25/03
50 titoli per investire in AI, salute, mobilità ed energia	22/03
50 Top-Aktien für Investitionen in KI, Gesundheit, Mobilität und Energie	22/03
50 valeurs pour investir dans l'IA, la Santé, la Mobilité et l'Energie	22/03
Recursion Pharmaceuticals Insider Sold Shares Worth $537,190, According to a Recent SEC Filing	15/03
Recursion Pharmaceuticals to Open London Office	11/03
Recursion Announces Plans to Open New Office in London	11/03
Recursion Announces Plans to Open New Office in London	11/03
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community	01/03
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community	01/03
Recursion to Participate in Upcoming Investor Conferences	01/03
Recursion to Participate in Upcoming Investor Conferences	01/03

Geen resultaten voor deze zoekopdracht